Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On ContraFect Corp (CFRX)

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don’t make them change their opinion towards a company. This time it may be different. During the third quarter we observed increased volatility and small-cap stocks underperformed the market. Hedge fund investor letters indicated that they are cutting their overall exposure, closing out some position and doubling down on others. Let’s take a look at the hedge fund sentiment towards ContraFect Corp (NASDAQ:CFRX) to find out whether it was one of their high conviction long-term ideas.

ContraFect Corp (NASDAQ:CFRX) was in 6 hedge funds’ portfolios at the end of September. ContraFect Corp (NASDAQ:CFRX) has seen an increase in hedge fund interest recently, which might come as a surprise, as the shares of the company declined 15.24% during the quarter. There were 5 hedge funds in our database with ContraFect Corp (NASDAQ:CFRX) positions at the end of the previous quarter. Let us find out more about hedge funds that hold a stake in the company.

At the end of this article, we will also compare ContraFect Corp (NASDAQ:CFRX) to other stocks, including Advent/Claymore Enhanced Growth & Income (NYSE:LCM), Ellington Residential Mortgage REIT (NYSE:EARN), and Protalix BioTherapeutics Inc. (NYSEMKT:PLX) to get a better sense of its popularity.

Follow Contrafect Corp (NASDAQ:CFRX)
Trade (NASDAQ:CFRX) Now!

In the eyes of most investors, hedge funds are viewed as unimportant, old financial vehicles of years past. While there are over 8000 funds in operation at the moment, our researchers look at the crème de la crème of this club, about 700 funds. Most estimates calculate that this group of people directs the majority of all hedge funds’ total capital, and by tracking their matchless picks, Insider Monkey has determined a few investment strategies that have historically exceeded the broader indices. Insider Monkey’s small-cap hedge fund strategy exceeded the S&P 500 index by 12 percentage points per year for a decade in their back tests.

With all of this in mind, we’re going to take a gander at the recent action regarding ContraFect Corp (NASDAQ:CFRX).

What does the smart money think about ContraFect Corp (NASDAQ:CFRX)?

Heading into Q4, a total of 6 of the hedge funds tracked by Insider Monkey were bullish on this stock, an increase of 20% from one quarter earlier. With hedgies’ positions undergoing their usual ebb and flow, there exists a select group of key hedge fund managers who were upping their holdings meaningfully (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Kevin Kotler’s Broadfin Capital has the number one position in ContraFect Corp (NASDAQ:CFRX), worth close to $6.3 million, corresponding to 0.4% of its total 13F portfolio. Sitting at the No. 2 spot is Matthew Strobeck of Birchview Capital, with a $2 million position; the fund has 1.2% of its 13F portfolio invested in the stock. Other hedge funds and institutional investors that are bullish comprise Bihua Chen’s Cormorant Asset Management, Adam Wright and Gary Kohler’s Blue Clay Capital, and Phill Gross and Robert Atchinson’s Adage Capital Management.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.